These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 28112047)
1. Venous thromboembolism during treatment with antipsychotics: Results of a drug surveillance programme. Letmaier M; Grohmann R; Kren C; Toto S; Bleich S; Engel R; Gary T; Papageorgiou K; Konstantinidis A; Holl AK; Painold A; Kasper S World J Biol Psychiatry; 2018 Apr; 19(3):175-186. PubMed ID: 28112047 [TBL] [Abstract][Full Text] [Related]
2. Neuroleptic malignant syndrome: evaluation of drug safety data from the AMSP program during 1993-2015. Schneider M; Regente J; Greiner T; Lensky S; Bleich S; Toto S; Grohmann R; Stübner S; Heinze M Eur Arch Psychiatry Clin Neurosci; 2020 Feb; 270(1):23-33. PubMed ID: 30506147 [TBL] [Abstract][Full Text] [Related]
3. Severe parkinsonism under treatment with antipsychotic drugs. Druschky K; Bleich S; Grohmann R; Engel RR; Toto S; Neyazi A; Däubl B; Stübner S Eur Arch Psychiatry Clin Neurosci; 2020 Feb; 270(1):35-47. PubMed ID: 31444566 [TBL] [Abstract][Full Text] [Related]
4. Venous Thromboembolism During Treatment with Antipsychotics: A Review of Current Evidence. Jönsson AK; Schill J; Olsson H; Spigset O; Hägg S CNS Drugs; 2018 Jan; 32(1):47-64. PubMed ID: 29423659 [TBL] [Abstract][Full Text] [Related]
5. Severe hair loss associated with psychotropic drugs in psychiatric inpatients-Data from an observational pharmacovigilance program in German-speaking countries. Druschky K; Bleich S; Grohmann R; Burda K; Frieling H; Hillemacher T; Neyazi A; Stübner S; Toto S Eur Psychiatry; 2018 Oct; 54():117-123. PubMed ID: 30193142 [TBL] [Abstract][Full Text] [Related]
6. Seizure rates under treatment with antipsychotic drugs: Data from the AMSP project. Druschky K; Bleich S; Grohmann R; Engel RR; Neyazi A; Stübner S; Toto S World J Biol Psychiatry; 2019 Nov; 20(9):732-741. PubMed ID: 30058414 [No Abstract] [Full Text] [Related]
7. Antipsychotic use and Risk of Venous Thromboembolism: A Meta-Analysis. Di X; Chen M; Shen S; Cui X Psychiatry Res; 2021 Feb; 296():113691. PubMed ID: 33421839 [TBL] [Abstract][Full Text] [Related]
8. A pharmacovigilance study of the association between antipsychotic drugs and venous thromboembolism based on Food and Drug Administration Adverse Event Reporting System data. Yan Y; Wang L; Yuan Y; Xu J; Chen Y; Wu B Expert Opin Drug Saf; 2024 Jun; 23(6):771-776. PubMed ID: 37615268 [TBL] [Abstract][Full Text] [Related]
9. Antipsychotic drugs and risk of idiopathic venous thromboembolism: a nested case-control study using the CPRD. Ishiguro C; Wang X; Li L; Jick S Pharmacoepidemiol Drug Saf; 2014 Nov; 23(11):1168-75. PubMed ID: 25195779 [TBL] [Abstract][Full Text] [Related]
10. Hyponatraemia during psychopharmacological treatment: results of a drug surveillance programme. Letmaier M; Painold A; Holl AK; Vergin H; Engel R; Konstantinidis A; Kasper S; Grohmann R Int J Neuropsychopharmacol; 2012 Jul; 15(6):739-48. PubMed ID: 21777511 [TBL] [Abstract][Full Text] [Related]
11. Assessing the Rate of Antipsychotic Use in Ambulatory Care Patients With a Venous Thromboembolism. Rarrick C; Saccone N; Hebbard A; Jones B Ann Pharmacother; 2020 Feb; 54(2):97-104. PubMed ID: 31416330 [No Abstract] [Full Text] [Related]
12. Increase of antipsychotic medication in depressive inpatients from 2000 to 2007: results from the AMSP International Pharmacovigilance Program. Konstantinidis A; Papageorgiou K; Grohmann R; Horvath A; Engel R; Kasper S Int J Neuropsychopharmacol; 2012 May; 15(4):449-57. PubMed ID: 21733242 [TBL] [Abstract][Full Text] [Related]
13. Antipsychotic Drugs and Risk of Developing Venous Thromboembolism and Pulmonary Embolism: A Systematic Review and Meta-Analysis. Arasteh O; Nomani H; Baharara H; Sadjadi SA; Mohammadpour AH; Ghavami V; Sathyapalan T; Sahebkar A Curr Vasc Pharmacol; 2020; 18(6):632-643. PubMed ID: 32066363 [TBL] [Abstract][Full Text] [Related]
14. [Venous thromboembolism as an adverse effect of antipsychotic treatment]. Bałkowiec-Iskra E; Cessak G; Kryńska Ł; Łoza B; Wojnar M Psychiatr Pol; 2014; 48(5):997-1014. PubMed ID: 25639019 [TBL] [Abstract][Full Text] [Related]
15. Cardiovascular Adverse Reactions During Antipsychotic Treatment: Results of AMSP, A Drug Surveillance Program Between 1993 and 2013. Friedrich ME; Winkler D; Konstantinidis A; Huf W; Engel R; Toto S; Grohmann R; Kasper S Int J Neuropsychopharmacol; 2020 Feb; 23(2):67-75. PubMed ID: 31504560 [TBL] [Abstract][Full Text] [Related]
16. Use of antipsychotics and risk of venous thromboembolism in postmenopausal women. A population-based nested case-control study. Wang MT; Liou JT; Huang YW; Lin CW; Wu GJ; Chu CL; Yeh CB; Wang YH Thromb Haemost; 2016 Jun; 115(6):1209-19. PubMed ID: 26941052 [TBL] [Abstract][Full Text] [Related]
17. Antipsychotic treatment and the occurrence of venous thromboembolism: a 10-year nationwide registry study. Wu CS; Lin CC; Chang CM; Wu KY; Liang HY; Huang YW; Tsai HJ J Clin Psychiatry; 2013 Sep; 74(9):918-24. PubMed ID: 24107765 [TBL] [Abstract][Full Text] [Related]
18. Antipsychotic drug use and the risk of venous thromboembolism in elderly patients with dementia. Schmedt N; Garbe E J Clin Psychopharmacol; 2013 Dec; 33(6):753-8. PubMed ID: 24052055 [TBL] [Abstract][Full Text] [Related]
19. Clozapine-associated adverse drug reactions in 38,349 psychiatric inpatients: drug surveillance data from the AMSP project between 1993 and 2016. Bleich L; Grohmann R; Greil W; Dabbert D; Erfurth A; Toto S; Seifert J J Neural Transm (Vienna); 2024 Sep; 131(9):1117-1134. PubMed ID: 39136776 [TBL] [Abstract][Full Text] [Related]
20. Antipsychotic Use Among Adult Outpatients and Venous Thromboembolic Disease: A Retrospective Cohort Study. Ferraris A; Szmulewicz AG; Vazquez FJ; Vollmer WM; Angriman F J Clin Psychopharmacol; 2017 Aug; 37(4):405-411. PubMed ID: 28622161 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]